Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Verena Schlintl, Florian Huemer, Gabriel Rinnerthaler, Thomas Melchardt, Thomas Winder, Patrick Reimann, Jakob Riedl, Arno Amann, Wolfgang Eisterer, Franz Romeder, Gudrun Piringer, Aysegül Ilhan-Mutlu, Ewald Wöll, Richard Greil & Lukas Weiss. (2022) Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort. BMC Cancer 22:1.
Crossref
Crossref
Sofia Sagredou, Panagiotis Dalezis, Eirini Papadopoulou, Maria Voura, Maria V. Deligiorgi, Michail Nikolaou, Mihalis I. Panayiotidis, George Nasioulas, Vasiliki Sarli & Dimitrios T. Trafalis. (2021) Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden. Pharmaceutics 13:6, pages 885.
Crossref
Crossref
M.J.M. van Velzen, S. Derks, N.C.T. van Grieken, N. Haj Mohammad & H.W.M. van Laarhoven. (2020) MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma. Cancer Treatment Reviews 86, pages 102024.
Crossref
Crossref
Antonella Di Sotto, Silvia Di Giacomo, Elisabetta Rubini, Alberto Macone, Marco Gulli, Caterina Loredana Mammola, Margherita Eufemi, Romina Mancinelli & Gabriela Mazzanti. (2020) Modulation of STAT3 Signaling, Cell Redox Defenses and Cell Cycle Checkpoints by β-Caryophyllene in Cholangiocarcinoma Cells: Possible Mechanisms Accounting for Doxorubicin Chemosensitization and Chemoprevention. Cells 9:4, pages 858.
Crossref
Crossref
Julie A. E. Irving. (2016) Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia. British Journal of Haematology 172:5, pages 655-666.
Crossref
Crossref
Jihong Zhang, Marc Hummersone, Charles S. Matthews, Malcolm F.G. Stevens & Tracey D. Bradshaw. (2015) N3-Substituted Temozolomide Analogs Overcome Methylguanine-DNA Methyltransferase and Mismatch Repair Precipitating Apoptotic and Autophagic Cancer Cell Death. Oncology 88:1, pages 28-48.
Crossref
Crossref
I-Chen Li, Chien-Yuan Chiu, Chang-Lin Wu, Jhih-Ying Chi, Siao-Ru Jian, Shainn-Wei Wang & Christina L. Chang. (2014) A dual-fluorescent reporter facilitates identification of thiol compounds that suppress microsatellite instability induced by oxidative stress. Free Radical Biology and Medicine 69, pages 86-95.
Crossref
Crossref
Stephany Veuger & Nicola J. Curtin. 2014. Cancer Drug Design and Discovery. Cancer Drug Design and Discovery
193
237
.
Long Shan Li, Mark Wagner, Mark Meyers & David A. Boothman. 2012. DNA Repair in Cancer Therapy. DNA Repair in Cancer Therapy
191
210
.
Andrew Best, Elizabeth Matheson, Lynne Minto, Andrew G. Hall & Julie A.E. Irving. (2010) Mismatch repair and the downstream target genes, PAX5 and Ikaros, in childhood acute lymphoblastic leukemia. Leukemia Research 34:8, pages 1098-1102.
Crossref
Crossref
Amy Peasland, Elizabeth Matheson, Andy Hall & Julie Irving. (2010) Alternative splicing of hMLH1 in childhood acute lymphoblastic leukaemia and characterisation of the variably expressed Δ9/10 isoform as a dominant negative species. Leukemia Research 34:3, pages 322-327.
Crossref
Crossref
Aksana Vasilyeva, Jill E. Clodfelter, Michael J. Gorczynski, Anthony R. Gerardi, S. Bruce King, Freddie Salsbury & Karin D. Scarpinato. (2010) Parameters of Reserpine Analogs That Induce MSH2/MSH6-Dependent Cytotoxic Response. Journal of Nucleic Acids 2010, pages 1-13.
Crossref
Crossref
Tao Yan, Yuji Seo & Timothy J. Kinsella. (2009) Differential Cellular Responses to Prolonged LDR-IR in MLH1-Proficient and MLH1-Deficient Colorectal Cancer HCT116 Cells. Clinical Cancer Research 15:22, pages 6912-6920.
Crossref
Crossref
Long Shan Li, Julio C Morales, Martina Veigl, David Sedwick, Sheldon Greer, Mark Meyers, Mark Wagner, Richard Fishel & David A Boothman. (2009) DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets. British Journal of Pharmacology 158:3, pages 679-692.
Crossref
Crossref
Aksana Vasilyeva, Jill E. Clodfelter, Brian Rector, Thomas Hollis, Karin D. Scarpinato & Freddie R. SalsburyJr.Jr.. (2009) Small molecule induction of MSH2-dependent cell death suggests a vital role of mismatch repair proteins in cell death. DNA Repair 8:1, pages 103-113.
Crossref
Crossref
Alice Machado-Silva, Santuza M.R. Teixeira, Glória R. Franco, Andréa M. Macedo, Sérgio D.J. Pena, Richard McCulloch & Carlos Renato Machado. (2008) Mismatch repair in Trypanosoma brucei: Heterologous expression of MSH2 from Trypanosoma cruzi provides new insights into the response to oxidative damage. Gene 411:1-2, pages 19-26.
Crossref
Crossref
Joanna Will, William S. Sheldrick & Dirk Wolters. (2007) Characterisation of cisplatin coordination sites in cellular Escherichia coli DNA-binding proteins by combined biphasic liquid chromatography and ESI tandem mass spectrometry. JBIC Journal of Biological Inorganic Chemistry 13:3, pages 421-434.
Crossref
Crossref
Elizabeth C. Matheson, Linda A. Hogarth, Marian C. Case, Julie A.E. Irving & Andrew G. Hall. (2007) DHFR and MSH3 co-amplification in childhood acute lymphoblastic leukaemia, in vitro and in vivo. Carcinogenesis 28:6, pages 1341-1346.
Crossref
Crossref
Robert M. Mader. (2006) Gender specific tumour pharmacology – from kinetics to geneticsVon der Pharmakokinetik zur Pharmakogenetik. Wiener Medizinische Wochenschrift 156:19-20, pages 545-548.
Crossref
Crossref
Federica Di Nicolantonio, Louise A. Knight, Pauline A. Whitehouse, Stuart J. Mercer, Sanjay Sharma, Peter A. Charlton, David Norris & Ian A. Cree. (2004)
The
ex vivo
characterization of XR5944 (MLN944) against a panel of human clinical tumor samples
. Molecular Cancer Therapeutics 3:12, pages 1631-1637.
Crossref
Crossref
Federica Di Nicolantonio, Louise A. Knight, Silvana Di Palma, Sanjay Sharma, Pauline A. Whitehouse, Stuart J. Mercer, Peter A. Charlton, David Norris & Ian A. Cree. (2004) Ex vivo characterization of XR11576 (MLN576) against ovarian cancer and other solid tumors. Anti-Cancer Drugs 15:9, pages 849-860.
Crossref
Crossref
Tao Yan, Anand B. Desai, James W. Jacobberger, R. Michael Sramkoski, Tamalette Loh & Timothy J. Kinsella. (2004) CHK1 and CHK2 are differentially involved in mismatch repair–mediated 6-thioguanine-induced cell cycle checkpoint responses. Molecular Cancer Therapeutics 3:9, pages 1147-1157.
Crossref
Crossref
Karin Drotschmann, Ryan P. Topping, Jill E. Clodfelter & Freddie R. Salsbury. (2004) Mutations in the nucleotide-binding domain of MutS homologs uncouple cell death from cell survival. DNA Repair 3:7, pages 729-742.
Crossref
Crossref
M Bignami, I Casorelli & P Karran. (2003) Mismatch repair and response to DNA-damaging antitumour therapies. European Journal of Cancer 39:15, pages 2142-2149.
Crossref
Crossref
Harvey W Mohrenweiser, David M WilsonIIIIII & Irene M Jones. (2003) Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 526:1-2, pages 93-125.
Crossref
Crossref
Peter Karran. (2001) Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis 22:12, pages 1931-1937.
Crossref
Crossref